- Investing Ideas
- U.S. Pharmaceuticals & Biotech Breakout Stocks
U.S. Pharmaceuticals & Biotech Breakout Stocks
Results
16
Stocks where the price continues to rise after more than a year of consistent gains.
16 companies
Corcept Therapeutics
Market Cap: US$12.8b
A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$114.49
7D
20.1%
1Y
65.9%
Avantor
Market Cap: US$9.3b
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
AVTR
US$13.78
7D
20.5%
1Y
21.3%
Bausch Health Companies
Market Cap: US$2.3b
Operates as a diversified specialty pharmaceutical and medical device company.
BHC
US$6.89
7D
55.5%
1Y
20.7%
Forte Biosciences
Market Cap: US$1.9b
Operates as a clinical-stage biopharmaceutical company in the United States.
FBRX
US$76.60
7D
39.8%
1Y
697.1%
Agenus
Market Cap: US$354.0m
A clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally.
AGEN
US$7.50
7D
25.4%
1Y
39.9%
Anika Therapeutics
Market Cap: US$241.8m
A joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally.
ANIK
US$19.28
7D
29.0%
1Y
123.1%
Entera Bio
Market Cap: US$145.4m
A clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally.
ENTX
US$2.99
7D
45.9%
1Y
53.3%
Yarrow Bioscience
Market Cap: US$98.1m
Operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases.
YARW
US$35.02
7D
37.6%
1Y
98.5%
Eloxx Pharmaceuticals
Market Cap: US$53.7m
A clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia.
ELOX
US$17.43
7D
46.0%
1Y
174,299,900.0%
BetterLife Pharma
Market Cap: US$28.5m
A biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada.
BETR.F
US$0.21
7D
41.3%
1Y
202.0%
Curative Biotechnology
Market Cap: US$9.2m
A biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications.
CUBT
US$1.48
7D
48.0%
1Y
6.1%
Panacea Life Sciences Holdings
Market Cap: US$5.5m
Operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals.
PLSH
US$0.092
7D
23.2%
1Y
185.1%
Rimrock Gold
Market Cap: US$576.8k
Through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts.
RMRK
US$0.0003
7D
20.0%
1Y
0%
Greater Cannabis Company
Market Cap: US$207.9k
Engages in the development and commercialization of cannabinoid therapeutics.
GCAN
US$0.33
7D
24.0%
1Y
48.9%
Affymax
Market Cap: US$111.7k
Does not have significant operations.
AFFY
US$0.0015
7D
50.0%
1Y
87.5%
PaxMedica
Market Cap: US$63.1k
A clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms.
PXMD
US$0.0007
7D
40.0%
1Y
600.0%